Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy
Cheung, D., Magee, D.E., Hird, A.E., Perlis, N., Finelli, A., Kulkarni, G.S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Cost-effectiveness analysis of the phase 3 IMvigor130 study evaluating atezolizumab as monotherapy or combined with platinum-based chemotherapy versus chemotherapy alone in locally advanced or metastatic urothelial cancer
Magee, D.E., Cheung, D.C., Hird, A.E., Sridhar, S.S., Fallah-Rad, N., Fleshner, N.E., Kulkarni, G.K.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials
Magee, D.E., Hird, A.E., Klaassen, Z., Sridhar, S.S., Nam, R.K., Wallis, C.J.D., Kulkarni, G.S.
Published in Annals of oncology (01.01.2020)
Published in Annals of oncology (01.01.2020)
Get full text
Journal Article
Moving beyond PSA: Identifying the optimal diagnostic strategy to assess prostate cancer risk
Cheung, D., Magee, D.E., Stonier, T., Briggs, A., Ferket, B., Finelli, A., Kulkarni, G.S., Vickers, A., Carlsson, S., Eastham, J.
Published in European urology (01.02.2022)
Published in European urology (01.02.2022)
Get full text
Journal Article
Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene HCl, tamoxifen, estrogen, and alendronate
Frolik, C.A., Bryant, H.U., Black, E.C., Magee, D.E., Chandrasekhar, S.
Published in Bone (New York, N.Y.) (01.06.1996)
Published in Bone (New York, N.Y.) (01.06.1996)
Get full text
Journal Article